Bindinglaw

US · guidance

CMS Pub. 100-04, ch. 32, § 11.3.4

Payment Method

activein force · 2026-08-25 – presentas-observed

Payment for PRP services is as follows:

• Hospital outpatient departments TOBs 12X and 13X – based on the Outpatient Prospective Payment System

• Skilled Nursing Facility TOBs 22X and 23X – based on the Medicare Physician Fee Schedule (MPFS)

• TOB 71X – based on the all-inclusive rate

• TOB 75X – based on the MPFS

• TOB 77X – based on the all-inclusive rate

• TOB 85X – based on reasonable cost

• Critical Access Hospitals TOB 85X and revenue codes 096X, 097X, or 098X – based on the MPFS

Local MACs shall pay for PRP services for hospitals in Maryland under the jurisdiction of the Health Services Cost

Review Commission on an outpatient basis, TOB 13X, in accordance with the terms of the Maryland waiver.

History

(Rev. 11214, Issued: 01-20-22, Effective:04-13-21, Implementation: 01-03-22 Shared Systems Contractors, 02- 14-22 MACs)

Provenance

Source
cms.gov
Retrieved
2026-08-25
Edition
iom-2026-08-25
Content hash
524c4d69b0967a45ed71b71243ab34fe12070747aec4e519cb5553adfac3a398
View the official source →

The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.

Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.

Coverage · API docs

Bindinglaw

Point-in-time US law with the receipt attached. Source URL, retrieval time, content hash, and validity dates on every answer.

curl api.binding.law/v1/law/coverage

© 2026 binding.law · a Jubal, Inc. productAttorneys and firms never pay. Ever.